Reversal of morphine with naloxone precipitates haloperidol-induced extrapyramidal side effects.
Guo
Shu-Lin
SL
Lin
Chen-Jung
CJ
Huang
Hsing-Hao
HH
Chen
Li-Kuei
LK
Sun
Wei-Zen
WZ
D000293:Adolescent; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000506:poisoning; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D004347:Drug Interactions; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D007278:Injections, Spinal; D009020:Morphine / Q000008:administration & dosage / Q000506:poisoning; D009270:Naloxone / Q000008:administration & dosage / Q000009:adverse effects*; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy
D000701:Analgesics, Opioid; D014150:Antipsychotic Agents; D009292:Narcotic Antagonists; D009270:Naloxone; D009020:Morphine; D006220:Haloperidol